Roy Jensen

19PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Health informatics and information systemsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 25, 2024
Selective targeting of IRAK1 attenuates low molecular weight hyaluronic acid-induced stemness and non-canonical STAT3 activation in epithelial ovarian cancer.

David Standing, Prasad Dandawate, Sumedha Gunewardena

|Dec 01, 2023
Cancer Prevention Perspective: The University of Kansas Cancer Center.

Roy A Jensen, Christie A Befort

|Jul 05, 2023
Understanding and Overcoming Immunosuppression Shaped by Cancer Stem Cells.

Linheng Li, Roy A Jensen

|Jul 28, 2022
Leadership Diversity and Development in the Nation's Cancer Centers.

Caryn Lerman, Chanita Hughes-Halbert, Mary Falcone

|Jan 19, 2022
Functional characterization of NPM1-TYK2 fusion oncogene.

Sudhakiranmayi Kuravi, Riley W Baker, Muhammad Umair Mushtaq

|Jul 02, 2021
Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis.

Dharmalingam Subramaniam, Sivapriya Ponnurangam, Satish Ramalingam

Pageof 4

Frequent Collaborators

6 joint publications

Shrikant Anant

4 joint publications

Scott J Weir

3 joint publications

Ramesh Balusu

3 joint publications

Dharmalingam Subramaniam